JB/PUT/GILEAD SCIENCES/90/0.05/20.09.24 Share Price

Warrant

GILGJB

CH1311831056

Market Closed - Bid/Ask 16:20:00 04/06/2024 BST After market 16:15:00
1.19 CHF -0.83% Intraday chart for JB/PUT/GILEAD SCIENCES/90/0.05/20.09.24 1.195 +0.42%
Current month-3.25%
1 month+2.59%
Date Price Change
04/06/24 1.19 -0.83%
03/06/24 1.2 -2.44%
30/05/24 1.23 -0.81%
29/05/24 1.24 +5.98%
28/05/24 1.17 +2.63%

Delayed Quote Swiss Exchange

Last update June 04, 2024 at 04:20 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying GILEAD SCIENCES, INC.
Issuer Bank Julius Bär
GILGJB
ISINCH1311831056
Date issued 09/01/2024
Strike 90 $
Maturity 20/09/2024 (106 Days)
Parity 20 : 1
Emission price 0.43 CHF
Emission volume N/A
Settlement cash
Currency CHF

Technical Indicators

Highest since issue 1.24 CHF
Lowest since issue 0.36 CHF
Spread 0.01 CHF
Spread %0.83%

Company Profile

Gilead Sciences, Inc. specializes in the development, manufacturing and marketing of therapeutic products. Net sales break down by source of income as follows: - sale of drugs (98.9%): for the treatment of HIV (63% of net sales), COVID-19 (20.4%), hepatitis C virus (6.6%), hepatitis B virus (3.6%) and other (6.4%; primarily cytomegalovirus retinitis, and advanced Kaposi sarcoma resulting from HIV); - other (1.1%): especially royalties and revenue from research and development services and from subcontracted production of therapeutic products. Net sales are distributed geographically as follows: the United States (69.2%), Europe (16.4%) and other (14.4%).
Sector
-
More about the company

Ratings for Gilead Sciences, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Gilead Sciences, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
63.88 USD
Average target price
82.7 USD
Spread / Average Target
+29.46%
Consensus
  1. Stock Market
  2. Warrants
  3. GILGJB Warrant
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW